FindTrial
Sign In

A clinical trial to compare the effects of ultrasound guided suprascapular nerve block by pulsed radiofrequency ablation and ultrasound guided suprascapular nerve block by methylprednisolone injection with lignocaine in improving upper limb function in hemiplegic patient with shoulder pain

Effectiveness of ultrasound guided suprascapular nerve block by pulsed radiofrequency ablation and methylprednisolone injection with lignocaine in improving upper limb function in hemiplegic patient with shoulder pain: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034025
Enrollment
60
Registered
2021-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Suprascapular nerve block: Ultrasound guided suprascapular nerve block by pulsed radiofrequency ablation Control Intervention1: Suprascapular nerve block: Ultrasound guided Suprascapula

Sponsors

Suman Deb
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed cases of stroke of duration of 3-6 months

Exclusion criteria

Exclusion criteria: Allergy to proposed injection agents (Lignocaine and Methylprednisolone) Systemic diseases like hepatitis, HIV, uncontrolled diabetes mellitus and hypertension Intra or periarticular steroid injection to shoulder in previous 3 month Any febrile or infectious diseases in last two weeks History of any malignancy Any history of trauma, fracture, bony malformation around the shoulder Patients with cardiac arrhythmia or a pacemaker Bleeding disorders Cognitive deficit

Design outcomes

Primary

MeasureTime frame
Upper arm function evaluated by MAS, SPADITimepoint: 1 week, 4 weeks, 12 weeks—

Secondary

MeasureTime frame
Pain by using VASTimepoint: 1 week, 4 weeks, 12 weeks—

Countries

India

Contacts

Public ContactDr N Bimol

Regional Institute of Medical Sciences

bimoldr@yahoo.com7005291542

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026